NewsBenzingaAdial Pharmaceuticals déclare que les actionnaires approuvent la conversion des actions privilégiées de série A en 12 930 601 actions, portant le nombre d’actions autorisées à 500 000 000 contre 100 000 000 auparavant Adial Pharmaceuticals déclare que les actionnaires approuvent la conversion des actions privilégiées de série A en 12 930 601 actions, portant le nombre d’actions autorisées à 500 000 000 contre 100 000 000 auparavant Benzinga 2026.10.28 20:43 (GMT+0) Open on Benzinga Other news Isomorphic Labs Raises $5 Billion for AI Drug Design “AI Stock God” Leopold’s Fund Makes Sweeping Exit From Bitcoin Mining Stocks: IREN Position Slashed 94%, Several Miners Liquidated Wells Fargo: Get Paid to Wait: or Buy at a Discount Is a $1,100 Solana Price Realistic? Bitwise’s Model Has One Big Condition Bitcoin Holds Near $64,800 as ETF Outflow Streak Ends Royal Caribbean Cruises Stock Outlook: Is Wall Street Bullish or Bearish?
“AI Stock God” Leopold’s Fund Makes Sweeping Exit From Bitcoin Mining Stocks: IREN Position Slashed 94%, Several Miners Liquidated